Risk Return Analysis Of Pharmaceuticals Companies During Covid-19

Year : 2024 | Volume :15 | Issue : 01 | Page : 1-6
By

    Vaishali.R. Panchal

  1. Assistant Professor, BBA College Mandvi Vajir ,dist-surat, Gujarat, India

Abstract

An unknown disease (COVID-19) is spreading globally, impacting people and economies very negatively. The virus, which was first discovered in a small part of China in December 2019, has since grown fast across more than 175 countries. The virus is very contagious, thus in order to stop it, certain measures have been put in place, such as a national shutdown, air traffic control, and the wearing of masks, avoidance of crowded locations, class contact conversations, and frequent hand sanitization. The virus also affected the India as a whole and also whole Indian economy. The main objective of this research paper was to study risk and return of pharmaceutical companies during covid -19 . The paper covers the statistical analysis of returns given by pharma companies during covid -19 and relationship has been found out between nifty and selected pharma companies and nifty and pharma index empirical analysis has been done using mark owitzs model by calculating risk, return , beta and correlation.it has been found that the co-relation of all selected companies are positive so it indicates that there is a positive relationship between Nifty and Pharmaceutical companies. Out of five companies Auro Pharma has more co-relation with Nifty Index. Based on the data collected during COVID-19, it is clear that the pharmaceutical industry and the Indian stock market have a close and mutually beneficial relationship. Further evidence of a co-movement relationship is provided by this result, which shows that the two variables move in tandem. During COVID-19, the pharmaceutical industry will feel the effects of stock market corrections just as sharply.

Keywords: Nifty, Nifty pharma, COVID-19, Indian Economy, Pharmaceutical companies

[This article belongs to Research & Reviews: A Journal of Pharmaceutical Science(rrjops)]

How to cite this article: Vaishali.R. Panchal Risk Return Analysis Of Pharmaceuticals Companies During Covid-19 rrjops 2024; 15:1-6
How to cite this URL: Vaishali.R. Panchal Risk Return Analysis Of Pharmaceuticals Companies During Covid-19 rrjops 2024 {cited 2024 Feb 27};15:1-6. Available from: https://journals.stmjournals.com/rrjops/article=2024/view=133822


Browse Figures

References

  1. “INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACEUTICAL SCIENCES: Effect on leading pharmaceutical stocks listed with NSE” (Aravind, M. and Manoj krishna, C. G., 2020, pp. 31-36).GUMBER, A. and BULSARI, S. (2020) COVID-19 Impact on Indian Economy and Health: The Emergence of Corona Economics.
  2. The Pharma Innovation Journal, 9(5), pp. 41–45, Jain, P., Baghla, K., and Aditya, R. (2020), “Effect of Corona/COVID19 on the Agricultural Sector in India.”
  3. Determinants of Social Distancing and Economic Activity During COVID-19: A Global Perspective, by Temel Taskin and W. Maloney (2020).
  4. The impacts of the coronavirus COVID-19 on the Indian economy were discussed in a 2020 study by Raj and Bahl.
  5. Ray, D. et al. (2020) Johns Hopkins University, “Predictions, role of interventions and effects of a historic national lockdown in India’s response to the COVID-19 pandemic: data science call to arms.”
  6. Tirivangani T, Alpon B, Kibuule D, Gaeseb J & Adenuge B.A, 2021. Impact of Covid19 pandemic on pharmaceutical systems and supply chain- a phenomenological study. Exploratory Research in Clinical and Social Pharmacy: 2.
  7. Rewari B B, Mangadan-Konath N & Sharma M. 2020. Impact of COVID-19 on the global supply chain of antiretroviral drugs: a rapid survey of Indian manufacturers. WHO South-East Asia Journal of Public health. 9(2): 126-133.
  8. Susarla N & Karimi I A. 2018. Integrated production planning and inventory management in multinational pharmaceutical supply chain. In: Computer Aided Chemical Engineering, Vol.41, pp. 551-567, Elsevier.
  9. Rahman Md. N, Mona S S, Noman S A A & Avi A D. 2020. COVID-19, Consumer behavior and inventory management: A study on the retail pharmaceutical industry of Bangladesh. Supply Chain Insider. 2(4): 201.. Ayati N, Saiyarsarai P, & Nikfar, S. 2020. Short- and Long-term impacts do COVID-19 on the pharmaceutical sector. DARU Journal of Pharmaceutical Sciences. 1-7.
  10. Rahman Md. N, Mona S S, Noman S A A & Avi A D. 2020. COVID-19, Consumer behavior and inventory management: A study on the retail pharmaceutical industry of Bangladesh. Supply Chain Insider. 2(4): 201.
  11. Agrawal, S.; Jamwal, A.; Gupta, S. Effect of COVID-19 on the Indian Economy and Supply ChainPreprints2020, 2020050148. https://doi.org/10.20944/preprints202005.0148.v1
  12. Gunaseelan, S. and Kesavan, N. (2020)‘BUSINESS AND ECONOMIC RECESSIONS IN INDIA DURING THE COVID-19 – A REVIEW’, Journal of Xi’an University ofArchitecture & Technology, XII(Iv), pp.356–366.

  13.https://www.nseindia.com

14.https://www.bseindia.com


Regular Issue Subscription Original Research
Volume 15
Issue 01
Received February 1, 2024
Accepted February 14, 2024
Published February 27, 2024